NIPMY yields 2.24% · PFE yields 6.13%● Live data
📍 NIPMY pulled ahead of the other in Year 1
Combined, NIPMY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NIPMY + PFE for your $10,000?
NH Foods Ltd. engages in the meat processing and packing business in Japan and internationally. The company's Processed Foods Business division offers hams and sausages primarily under the SCHAU ESSEN and Utsukushi-no-Kuni brands; and deli and processed foods primarily under the Chuka Meisai and Ishigama Kobo brand names. Its Fresh Meats Business division is involved in the production and raising, slaughtering, processing, distribution, and sale of fresh meat products. The company's Affiliated Business division produces and sells marine products and dairy products. This segment procures, processes, produces, and sells marine products, such as seafood salads, Chinese jellyfish, and other delicacies, as well as mackerels to supermarkets, restaurants, and other customers; and offers cheese products under the ROLF brand name to bakeries, confectionery makers, and convenience store chains, as well as yogurt and lactic acid probiotic beverages under the Luna brand name. It also engages in the provision of freeze-dried foods, meat extracts, and health foods; and information, accounting, personnel system design, human resource development, welfare programs, and architectural design services, as well as trading and sports activities. The company was formerly known as Nippon Meat Packers Inc. and changed its name to NH Foods Ltd. in June 2014. NH Foods Ltd. was founded in 1942 and is headquartered in Osaka, Japan.
Full NIPMY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.